Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients
Abstract
, and Genentech; he has served as DMSC member for AllergyCare; he or his institution have received speaker honoraria from Biogen Idec, Teva Neuroscience, Merck Serono, Medimmune, Novartis, Desitin, and F. Hoffmann-La Roche Ltd.; his institution has received research support from Chugai Pharmaceuticals and Hoffmann-La-Roche; he holds part of 2 patents-1 for the detection of antibodies and T cells against KIR4.1 in a subpopulation of MS patients and 1 for genetic determinants of neutralizing antibodies to interferon β. EKH has received honoraria/research support from Actelion, Biogen, Czech Ministry of Education project PROGRES Q27/LF1,